Discovery of IRAK4 Inhibitors <b>BAY1834845</b> (Zabedosertib) and <b>BAY1830839</b>-Reference-Cited by-同舟云学术

Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839

Published:2024-01-17 Issue:2 Volume:67 Page:1225-1242
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Bothe Ulrich¹^ORCID,Günther Judith¹^ORCID,Nubbemeyer Reinhard¹,Siebeneicher Holger¹,Ring Sven¹,Bömer Ulf¹,Peters Michaele¹,Rausch Alexandra¹^ORCID,Denner Karsten¹,Himmel Herbert¹,Sutter Andreas¹,Terebesi Ildiko¹,Lange Martin¹^ORCID,Wengner Antje M.¹,Guimond Nicolas¹,Thaler Tobias¹,Platzek Johannes¹,Eberspächer Uwe¹,Schäfer Martina¹,Steuber Holger¹,Zollner Thomas M.¹,Steinmeyer Andreas¹,Schmidt Nicole¹

Affiliation:

1. Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany

Funder

Bayer

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c01714

Reference51 articles.

1. The interleukin-1 receptor-associated kinases: Critical regulators of innate immune signalling

2. Innate Immune Recognition

3. Immunological and Inflammatory Functions of the Interleukin-1 Family